
Cymra receives its ODC permit
Cymra has been granted permits from the Office of Drug Control for cultivation and manufacture on its site in the Northern Rivers of NSW The
Cymra has been granted permits from the Office of Drug Control for cultivation and manufacture on its site in the Northern Rivers of NSW The
CYDEPS – Dose escalation pain study The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential treatment for chronic
Cymra’s flagship clinical product Cybis is now released an on the market through our distributor. Its Australian grown cannabis under Good Agricultural Practice and Australian
Cymra Pharma is pleased to announce John Montgomery as an Executive Director to the Board. John comes with 40yrs of pharmaceutical experience in the US,
Sometimes its hard to keep up to date with the latest Plant Medicine Information in Australia. Let us know if we can help
© 2021 Cymra Life Sciences – ABN 54 621 123 760